Get the Daily Brief
Latest Biotech News
FDA and Vaccine Safety Data Stir Public Health Debate
The FDA plans to present data alleging 25 child deaths linked to COVID-19 vaccines at an upcoming CDC advisory meeting. The analysis leverages VAERS, a self-reported database, which experts...
AI and Machine Learning Accelerate Drug Discovery and Diagnostics
The application of AI in biotechnology continues to deepen, exemplified by multiple initiatives. VedaBio licensed critical CRISPR IP from Mammoth Biosciences, enhancing its amplification-free...
Merck Exits UK, Spotlights Policy Concerns Amid US Growth
Merck has announced its exit from research and development activities in the United Kingdom, citing concerns about the country's life sciences policies. This move comes as Merck simultaneously...
Avidity and Remynd Report Positive Data in Rare and Neurodegenerative Diseases
Avidity Biosciences announced encouraging early and mid-stage trial results for del-zota, an antibody-oligonucleotide conjugate addressing Duchenne muscular dystrophy (DMD). Patients treated...
LPHCs Fundraise Big as Biotech Startups Gain Momentum
Lila Sciences is reportedly nearing a Series A funding round exceeding $300 million to advance autonomous scientific discovery using AI, while Goodpath secured $18 million for its chronic...
Soil Metagenome Sequencing Uncovers Novel Antibiotics and Microbial Diversity
Researchers at Rockefeller University have harnessed terabase-scale long-read sequencing technologies to unravel complex soil microbial genomes, which are largely uncultivable in laboratory...
FDA Biosimilars Adoption Faces PBM Barriers despite Significant Savings
A recent report highlights that biosimilars approved by FDA have generated over $56 billion in savings since 2015, yet their market adoption remains uneven across therapeutic areas. Pharmacy...
AI Peptide Design and Protein Therapeutics Gain Research Momentum
AI and machine learning are revolutionizing peptide and protein drug development. Professor Peter ‘t Hart highlights breakthroughs in sustainable peptide synthesis powered by AI-designed molecules...
Ultima Genomics and Sapio Sciences Partner to Streamline Multiomics Workflows
Ultima Genomics and Sapio Sciences have formed a strategic partnership integrating Sapio’s AI-driven lab informatics with Ultima’s high-throughput, low-cost sequencing platform. This collaboration...
Nanomedicine and Targeted Drug Delivery Advance Cancer Therapeutics
Researchers continue to innovate in nanomedicine to overcome obstacles in targeting metastatic cancer. New advancements include poly-L-histidine-coated mesoporous silica nanoparticles designed for...
Regulatory and Funding Updates in Biopharma
The European Medicines Agency has extended the mandate of its head, Amanda Adler Cooke. Health Canada announced measures to streamline regulatory inspections by recognizing other regulators’...
Advances in Cancer Biology and Immunotherapy Targets
Recent studies reveal novel mechanisms in tumor biology and immunotherapy. Exploration of tumor microenvironment dynamics using single-cell and spatial omics reveals cellular interactions...
Novo Nordisk's Workforce Overhaul, Office Return Amid Market Pressure
Novo Nordisk has announced a major restructuring, cutting 9,000 jobs in response to slowing sales and heightened competition in obesity and diabetes markets. The company has also mandated...
AI and Informatics: Ultima Genomics Partners with Sapio Sciences on Multi-Omics
Ultima Genomics and Sapio Sciences have formed a strategic partnership to integrate Sapio's AI-driven lab informatics with Ultima's advanced high-throughput sequencing platform. This collaboration...
Breakthrough in Soil Metagenomics Reveals New Antibiotics Potential
Researchers at Rockefeller University have applied terabase-scale long-read sequencing to soil metagenomes, uncovering hundreds of previously unknown bacterial genomes and identifying two new...
Remynd and Avidity Show Promising Data in Neurodegenerative and Muscular Diseases
Remynd NV reported positive phase IIa trial results for its Alzheimer’s drug REM-127, demonstrating cognitive improvement by restoring neuronal calcium homeostasis and reducing pathological tau...
FDA and Regulatory Developments Amid Industry Shifts
Vinay Prasad has regained chief medical and scientific officer roles at the FDA’s Center for Biologics Evaluation and Research. Meanwhile, the FDA denies reports about abandoning some advisory...
Liver Cancer and Metabolism: Ether-Lipid and Genetic Insights
New research links ether-lipid accumulation to hepatocellular carcinoma progression, revealing metabolic pathways that may drive tumor growth. Separately, non-coding RNAs have been shown to...
Advances in Alzheimer’s Disease Mechanisms and Therapeutics
A study identifies familial Alzheimer’s mutations disrupting exosome release from brain cells, which may impair neurotrophic support and contribute to disease progression. Concurrently, Remynd’s...
Biopharma Financing and Market Trends in 2025
Biopharma deal values have surged to a record $185 billion through August 2025, reflecting robust investment despite some sector challenges. Series A and later-stage financings, including Penguin...